Concepedia

Susan Lu

SL

Statistics

Publications

23

Citations

2K

H-Index

18

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

National Jewish Health

University of Colorado Denver

University of Cincinnati

Bernstein Clinical Research Center

Susan Lu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, pharmacology, and hypersensitivity.

Publications per year

1999–2023

23

Publications

23

Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma

Michel Laviolette, Kerstin Malmström, Susan Lu et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 353 citations

, , +17

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial

Eli O. Meltzer, Kerstin Malmström, Susan Lu et al. · Journal of Allergy and Clinical Immunology · 2000 · 309 citations · Full text

, , +15

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, David C. Dale, James F. Donohue et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 258 citations

, , +16

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

Anjuli Nayak, George Philip, Susan Lu et al. · Annals of Allergy Asthma & Immunology · 2002 · 203 citations

, , +12

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Hendrik Nolte, Jennifer Maloney, Harold S. Nelson et al. · Journal of Allergy and Clinical Immunology · 2015 · 160 citations

, , +17

1–5 of 23